Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting Employee Directory

Biotechnology ResearchFlorida, United States11-50 Employees

The DuraGraft® Difference: DuraGraft is a vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure. 

Not Available In The United States.

Find Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting employees' phone numbers or email addresses

Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting Global Highlights

Location
Employees

North America
23

Minus sign iconPlus sign icon
  • United States Of America
    22
  • Canada
    1

Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's Leadership

  • Stylized image of a person
    J. C.
    Vice President - Regulatory Affairs And Quality
    Phone icon
  • Stylized image of a person
    B. C.
    Sr.Director, Product Development
    Phone icon
  • Stylized image of a person
    B. C.
    Sr.Director, Product Development
    Phone icon
  • Stylized image of a person
    M. O.
    Director Procurement And Supply Chain Operations
    Phone icon
  • Stylized image of a person
    V. S.
    Director, Global Clinical Affairs
    Phone icon
  • Stylized image of a person
    C. R.
    Manager, Analytical Services
    Phone icon
  • Stylized image of a person
    J. R.
    Clinical Operations Manager
    Phone icon
  • Stylized image of a person
    K. C. M. C.
    Marketing Communications Manager
    Phone icon

Contact profiles from Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    J. C.
    Vice President - Regulatory Affairs And Quality
    Phone icon
    UNITED STATES
    Mar 08, 2023
  • Stylized image of a person
    B. C.
    Sr.Director, Product Development
    Phone icon
    United StatesMassachusetts
    Oct 22, 2025
  • Stylized image of a person
    B. C.
    Sr.Director, Product Development
    Phone icon
    United StatesMassachusetts
  • Stylized image of a person
    M. O.
    Director Procurement And Supply Chain Operations
    Phone icon
    UNITED STATES
    Mar 08, 2023
  • Stylized image of a person
    V. S.
    Director, Global Clinical Affairs
    Phone icon
    United StatesFlorida
    Oct 23, 2024
  • Stylized image of a person
    C. R.
    Manager, Analytical Services
    Phone icon
    United StatesFlorida
    May 23, 2025
  • Stylized image of a person
    J. R.
    Clinical Operations Manager
    Phone icon
    UNITED STATES
    Mar 08, 2023
  • Stylized image of a person
    K. C. M. C.
    Marketing Communications Manager
    Phone icon
    United StatesFlorida
    Sep 11, 2024
  • Stylized image of a person
    T. W.
    Asset Protection Team Lead
    Phone icon
    UNITED STATES
    Mar 08, 2023
  • Stylized image of a person
    C. R.
    Analytical Services Manager
    Phone icon
    United States
    Oct 20, 2025

Frequently Asked Questions

What is Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting known for?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting was founded in 2010 operates in the Biotechnology Research industry. The company's main headquarters is located in 225 Chimney Corner Lane, Suite 2001; you can contact the main corporate office by phone at . Explore Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's company overview page for more information.

What is Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's most common email format?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting email formats with LeadIQ.

How many employees does Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting have currently?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting has approximately 20 employees as of December 2025. These team members are located across 1 continents, including North America.

Who are Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's key employees and leadership?

Minus sign iconPlus sign icon

As of December 2025, Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's key employees include:

  • Vice President - Regulatory Affairs And Quality: J. C.
  • Sr.Director, Product Development: B. C.
  • Sr.Director, Product Development: B. C.
  • Director Procurement And Supply Chain Operations: M. O.
  • Director, Global Clinical Affairs: V. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.